2022 | Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model | Chen, Yun-Ti; Chang, Yu-Hsiu; Pathak, Nikhil; Tzou, Shey-Cherng; Luo, Yong-Chun; Hsu, Yen-Chao; Li, Tian-Neng; Lee, Jung-Yu; Chen, Yi-Cyun; Huang, Yu-Wei; Yang, Hsin-Ju; Hsu, Nung-Yu; Tsai, Hui-Ping; Chang, Tein-Yao; Hsu, Shu-Chen; Liu, Ping-Cheng; Chin, Yuan-Fan; Lin, Wen-Chin; Yang, Chuen-Mi; Wu, Hsueh-Ling; Lee, Chia-Ying; Hsu, Hui-Ling; Liu, Yi-Chun; Chu, Jhih-Wei; Wang, Lily Hui-Ching; JANN-YUAN WANG ; Huang, Chih-Heng; Lin, Chi-Hung; Hsieh, Po-Shiuan; Wu Lee, Yan-Hwa; Hung, Yi-Jen; Yang, Jinn-Moon | Frontiers in immunology | 1 | 0 | |
2022 | A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant | Chang, Yi-Chung; Yang, Chi-Fan; Chen, Yi-Fen; Yang, Chia-Chun; Chou, Yuan-Lin; Chou, Hung-Wen; Chang, Tein-Yao; TAI-LING CHAO ; Hsu, Shu-Chen; Ieong, Si-Man; Tsai, Ya-Min; Liu, Ping-Cheng; Chin, Yuan-Fan; Fang, Jun-Tung; Kao, Han-Chieh; Lu, Hsuan-Ying; Chang, Jia-Yu; Weng, Ren-Shiuan; Tu, Qian-Wen; Chang, Fang-Yu; Huang, Kuo-Yen; Lee, Tong-Young; SUI-YUAN CHANG ; PAN-CHYR YANG | EMBO molecular medicine | 21 | 17 | |